SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations
3 references·3 citing·18 second hop
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations (2019)Estimating Lifetime Benefits Associated w…Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Recommendations for Conduct, …Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data (2013)Survival Analysis for Economi…Decision Modelling For Health Economic Evaluation (2006)Decision Modelling For Health…Novel and existing flexible survival methods for network meta-analyses (2022)Novel and existing flexible s…Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective (2020)Current challenges for assess…Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes (2019)Evaluating Partitioned Surviv…Cost-Effectiveness in Health and Medicine (1996)Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves (2012)Planning for Long-Term Follow-Up: Strategies Learned from Longitudinal Studies (2015)Partitioned Survival and State Transition Models for Healthcare Decision Making in Oncology: Where Are We Now? (2020)Methods for the Economic Evaluation of Health Care Programmes (2005)Understanding Costs of Care in the Operating Room (2018)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes (2016)Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling (2016)Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation (2017)Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies (2017)Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making (2018)Network Meta‐Analysis for Decision Making (2018)Multilevel Network Meta-Regression for Population-Adjusted Treatment Comparisons (2020)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Evidence Synthesis for Decision Making 2 (2012)Model Parameter Estimation and Uncertainty Analysis (2012)
this work references cited by second hop

References

  • 2006Decision Modelling For Health Economic Evaluation3,144 cited
  • 2016Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses3,063 cited
  • 2013Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data541 cited

Cited by

  • 2019Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes61 cited
  • 2020Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective53 cited
  • 2022Novel and existing flexible survival methods for network meta-analyses7 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work